Products with Increase obesity agents bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN3918 | Dodoviscin H |
| 1. Dodoviscin H can promote adipocyte differentiation as characterized by increased triglyceride levels in 3T3L1 cells. | |
| BCN3926 | Dodoviscin I |
| 1. Dodoviscin I can promote adipocyte differentiation as characterized by increased triglyceride levels in 3T3L1 cells. | |
| BCN3927 | Dodoviscin A |
| 1. Dodoviscin A can inhibit melanin biosynthesis induced by 3-isobutyl-1-methylxanthine and PD98059, it may be a new promising pigmentation-altering agent for cosmetic and therapeutic applications. 2. Dodoviscin A can promote adipocyte differentiation as characterized by increased triglyceride levels in 3T3L1 cells. 3. Dodoviscin A can enhance the accumulation of lipid droplets and induce upregulation of the expression of the adipocyte-specific genes aP2 and GLUT4. | |
| BCN3945 | Dodoviscin J |
| 1. Dodoviscin J can promote adipocyte differentiation as characterized by increased triglyceride levels in 3T3L1 cells. | |
| BCN4969 | Fructose |
| Fructose is a simple ketonic monosaccharide found in many plants. Dietary fructose can specifically increase hepatic de novo lipogenesis (DNL), promote dyslipidemia, decreases insulin sensitivity, and increase visceral adiposity in overweight/obese adults; it also can reduce circulating insulin and leptin, attenuate postprandial suppression of ghrelin, and increase triglycerides in women. | |
